Showing 13 to 23 of 23 results
Trump Executive Order Targets Drug Prices, Medicare Costs
President Trump issued a multi-part executive order on Tuesday aiming to lower drug prices and reduce Medicare costs by modifying Medicare drug price negotiations, standardizing Medicare payments for prescription drugs, and increasing transparency in pharmaceutical pricing; however, some provisions ...
Trump Executive Order Targets Drug Prices, Medicare Costs
President Trump issued a multi-part executive order on Tuesday aiming to lower drug prices and reduce Medicare costs by modifying Medicare drug price negotiations, standardizing Medicare payments for prescription drugs, and increasing transparency in pharmaceutical pricing; however, some provisions ...
Progress
40% Bias Score
Trump's Pharmaceutical Tariffs: Higher Prices, Shortages, Uncertain Production Boost
President Trump's announcement of major tariffs on pharmaceutical imports aims to boost domestic drug manufacturing but may instead increase drug prices and shortages, impacting patient access to essential medicines, with any increase in US production years away.
Trump's Pharmaceutical Tariffs: Higher Prices, Shortages, Uncertain Production Boost
President Trump's announcement of major tariffs on pharmaceutical imports aims to boost domestic drug manufacturing but may instead increase drug prices and shortages, impacting patient access to essential medicines, with any increase in US production years away.
Progress
52% Bias Score
Alabama Senate Passes Bill to Protect Community Pharmacies from PBM Reimbursement Issues
The Alabama Senate passed a bill mandating minimum reimbursement rates for community pharmacists to combat the closure of dozens of independent pharmacies across the state due to insufficient payments from pharmacy benefit managers; this bill now moves to the House.
Alabama Senate Passes Bill to Protect Community Pharmacies from PBM Reimbursement Issues
The Alabama Senate passed a bill mandating minimum reimbursement rates for community pharmacists to combat the closure of dozens of independent pharmacies across the state due to insufficient payments from pharmacy benefit managers; this bill now moves to the House.
Progress
44% Bias Score
Trump Tariffs Increase Healthcare Costs, but Impact Varies Across Sectors
President Trump's tariffs on China are expected to increase healthcare costs, particularly for generic drugs and medical devices, impacting 84% of consumers according to a Black Book Research survey, although the effect varies widely across the sector due to differing levels of reliance on Chinese i...
Trump Tariffs Increase Healthcare Costs, but Impact Varies Across Sectors
President Trump's tariffs on China are expected to increase healthcare costs, particularly for generic drugs and medical devices, impacting 84% of consumers according to a Black Book Research survey, although the effect varies widely across the sector due to differing levels of reliance on Chinese i...
Progress
40% Bias Score
Iran's Medicine Crisis: Price Hikes, Shortages, and Hospital Thefts
Due to reduced government subsidies, a rise in the dollar's exchange rate, and raw material shortages, medicine prices in Iran have sharply increased, causing shortages, hospital drug thefts, and endangering patients; the government's debt to the pharmaceutical industry and insurance companies furth...
Iran's Medicine Crisis: Price Hikes, Shortages, and Hospital Thefts
Due to reduced government subsidies, a rise in the dollar's exchange rate, and raw material shortages, medicine prices in Iran have sharply increased, causing shortages, hospital drug thefts, and endangering patients; the government's debt to the pharmaceutical industry and insurance companies furth...
Progress
40% Bias Score
China Expands Medical Insurance, Cutting Drug Prices by 63%
China's National Healthcare Security Administration added 91 drugs to its medical insurance scheme in 2024, reducing patient costs by an estimated 7 billion USD and expanding coverage for various diseases, including tumors, diabetes, and rare diseases.
China Expands Medical Insurance, Cutting Drug Prices by 63%
China's National Healthcare Security Administration added 91 drugs to its medical insurance scheme in 2024, reducing patient costs by an estimated 7 billion USD and expanding coverage for various diseases, including tumors, diabetes, and rare diseases.
Progress
40% Bias Score
Trump's Pharmaceutical Tariffs: Higher Prices, Shortages, and Uncertain Domestic Production
President Trump announced major tariffs on pharmaceutical imports, expected to increase drug prices and worsen shortages, while the impact on domestic manufacturing remains debated and years away.
Trump's Pharmaceutical Tariffs: Higher Prices, Shortages, and Uncertain Domestic Production
President Trump announced major tariffs on pharmaceutical imports, expected to increase drug prices and worsen shortages, while the impact on domestic manufacturing remains debated and years away.
Progress
48% Bias Score
Trump's Tariffs Set to Hike Drug Prices
President Trump's new tariffs will likely increase prices for many drugs, potentially adding $750 million to costs from Canadian imports alone, with further increases if extended to other countries; the U.S. relies heavily on imports for active pharmaceutical ingredients.
Trump's Tariffs Set to Hike Drug Prices
President Trump's new tariffs will likely increase prices for many drugs, potentially adding $750 million to costs from Canadian imports alone, with further increases if extended to other countries; the U.S. relies heavily on imports for active pharmaceutical ingredients.
Progress
52% Bias Score
PBMs Delay Life-Saving Medications: Urgent Call for Congressional Reform
A cancer center CEO details a 10-week delay in her daughter's medication approval due to PBM interference, highlighting the systemic issues causing patient suffering and the need for immediate Congressional reform to prioritize patients over profits, despite a failed attempt in 2024.
PBMs Delay Life-Saving Medications: Urgent Call for Congressional Reform
A cancer center CEO details a 10-week delay in her daughter's medication approval due to PBM interference, highlighting the systemic issues causing patient suffering and the need for immediate Congressional reform to prioritize patients over profits, despite a failed attempt in 2024.
Progress
60% Bias Score
Kennedy's Controversial Patent Seizure Plan Faces Senate Scrutiny
President Trump's nominee for HHS Secretary, Robert F. Kennedy Jr., is facing Senate confirmation hearings amid controversy over his reported openness to seizing drug patents to control prices—a policy that experts warn could severely damage the U.S. biotech industry and broader economy.
Kennedy's Controversial Patent Seizure Plan Faces Senate Scrutiny
President Trump's nominee for HHS Secretary, Robert F. Kennedy Jr., is facing Senate confirmation hearings amid controversy over his reported openness to seizing drug patents to control prices—a policy that experts warn could severely damage the U.S. biotech industry and broader economy.
Progress
60% Bias Score
575 Brand-Name Drug Prices Increase in Early 2025
On January 1st and 2nd, 2025, 575 brand-name drugs increased in price, including Ozempic and Paxlovid; the median increase was 4%, exceeding inflation and potentially impacting consumer costs depending on insurance coverage and formulary placement.
575 Brand-Name Drug Prices Increase in Early 2025
On January 1st and 2nd, 2025, 575 brand-name drugs increased in price, including Ozempic and Paxlovid; the median increase was 4%, exceeding inflation and potentially impacting consumer costs depending on insurance coverage and formulary placement.
Progress
36% Bias Score
Showing 13 to 23 of 23 results